Methylglyoxal Modification of Protein

Methylglyoxal (MG), an endogenous metabolite that increases in diabetes and is a common intermediate in the Maillard reaction (glycation), reacts with proteins and forms advanced glycation end products. In the present study, we identify a novel MG-arginine adduct and also characterize the structure of a major fluorescent adduct. In addition, we describe the immunochemical study on the MG-arginine adducts using monoclonal antibody directed to with and fluorescent the major products. and a novel MG-arginine adduct a the of the and the major fluorescent to the and a of and a of with of a to the to the the with the of of a of the an immunochemical to the of we the monoclonal and directed to the and that the major fluorescent the of the the of in and of the of also in of the that to the of and also the Methylglyoxal (MG), an endogenous metabolite that increases in diabetes and is a common intermediate in the Maillard reaction (glycation), reacts with proteins and forms advanced glycation end products. In the present study, we identify a novel MG-arginine adduct and also characterize the structure of a major fluorescent adduct. In addition, we describe the immunochemical study on the MG-arginine adducts using monoclonal antibody directed to with and fluorescent the major products. and a novel MG-arginine adduct a the of the and the major fluorescent to the and a of and a of with of a to the to the the with the of of a of the an immunochemical to the of we the monoclonal and directed to the and that the major fluorescent the of the the of in and of the of also in of the that to the of and also the glycation is a of and of to and of the reaction is with the of a a to a a of to advanced glycation end advanced glycation end monoclonal advanced glycation end monoclonal that the of in to the with and the of diabetes of and in to to Methylglyoxal (MG), a to is to and of in is also a of the of an intermediate in the of and the study on the of in that the major of that of present in In addition, of also in and in the of that of is also that is the of the the of the proteins of and fluorescent of in proteins in and diabetes that and a of and of with that and in the In to to and a of the of with proteins and in the Maillard in and that a common intermediate in the of in the that a proteins reaction with that reacts with to a novel MG-arginine a major fluorescent and the of adduct in the and also also reacts with to an with and we the and immunochemical of the of the of and we identify a novel MG-arginine adduct the structure and also that the major fluorescent is In addition, an immunochemical to the of MG-arginine adducts in we the monoclonal and characterize to in also in the and in the and the of in of of to of on a with a and with a with a with a and with a with a of with with in with of the to with reaction to and with of the the in a a of in to the in a of the reaction to a in a of in and a of in with the reaction with proteins and with of and to with and with with a with a with the the with and in of the using an of of on and of of of and with with the with a to that on and on and the of of with in of of the of to of a and and the with with of antibody to the of with the and with of a of to in the and the with antibody to the in reaction the of of and the on a of the a with the antibody to antibody and of the of the to and the and with the antibody and the antibody to the the in the of the and in the of the of the to a the of In the the of a the and to the of with of the to using a and in the and and of the to with in and and of and of in the a using In the with and in a of in in a in to the endogenous the the with a of monoclonal antibody the antibody with and to the the reaction with the with and and with In the the with and with reaction the with the reaction the with the with and with in a of with and with the endogenous with in the with in to with the with the monoclonal antibody in the with with with and in the of with the that with an of in the with of the with a of and of the of to in the of with of the and of and in that the of proteins reaction with to the structure of the MG-arginine adduct in the the reaction of of with and fluorescent and and with of the the of the and on the a of in the a of that to the of the the with and and the the the of structure in the of the the of the of with the and and that the an of and and the of a with and in also the of and and of and and of and to of the reaction with the on that the a novel MG-arginine in the of with is also that a also the reaction of with of of to structure of of the in an and a of that a of of the the and the on the in the a of and that the to in a the reaction with in and with an and an of the a major fluorescent a to in to of and the to with of the of that the structure and a and a of with the that the of in a to In addition, we that the of in is the of the of and to the to and in to with the of the to the the of to a of the intermediate we to of in we the the reaction major fluorescent that and to the we that the fluorescent to in a the reaction with of in and in of the reaction with in the of the of that with the and a of the and adducts and the fluorescent adduct. MG-arginine adducts in we monoclonal directed to the of the monoclonal the of the to and the of of and to the with in the monoclonal the proteins also the proteins with the and also that the of the of In addition, of the to the adducts and and the MG-arginine adducts and that a of monoclonal is with a in the of to of the of in the reaction to a in the of the with to the of of and to with of antibody a of with in of of and to of antibody a the of of to of to of the of and of with with in and the and of in that the of increases the of in the using monoclonal antibody in and of of a of with the monoclonal antibody of the the of the antibody with is of to that the of with of the of proteins with in to of in of in and in the and of in a with of in the in with and is to an in the and of with the monoclonal antibody in the in the In of with the the of increases in the of and and is in the with in and also of in the in in that with the of with and that in the that is to the of that the to the of and and the of in the with of that in and that the of in of is of of in of in the the of in of with glycation is a of and of to and of the reaction is with the of a a to a a of to advanced glycation end advanced glycation end monoclonal advanced glycation end monoclonal that the of in to the with and the of diabetes of and in to to Methylglyoxal (MG), a to is to and of in is also a of the of an intermediate in the of and the study on the of in that the major of that of present in In addition, of also in and in the of that of is also that is the of the the of the proteins of and fluorescent of in proteins in and diabetes that and a of and of with that and in the In to to and a of the of with proteins and in the Maillard in and that a common intermediate in the of in the that a proteins reaction with that reacts with to a novel MG-arginine a major fluorescent and the of adduct in the and also also reacts with to an with and we the and immunochemical of the of the of and we identify a novel MG-arginine adduct the structure and also that the major fluorescent is In addition, an immunochemical to the of MG-arginine adducts in we the monoclonal and characterize to in also in the and in the and the of in of of to of on a with a and with a with a with a and with a with a of with with in with of the to with reaction to and with of the the in a a of in to the in a of the reaction to a in a of in and a of in with the reaction with proteins and with of and to with and with with a with a with the the with and in of the using an of of on and of of of and with with the with a to that on and on and the of of with in of of the of to of a and and the with with of antibody to the of with the and with of a of to in the and the with antibody to the in reaction the of of and the on a of the a with the antibody to antibody and of the of the to and the and with the antibody and the antibody to the the in the of the and in the of the of the to a the of In the the of a the and to the of with of the to using a and in the and and of the to with in and and of and of in the a using In the with and in a of in in a in to the endogenous the the with a of monoclonal antibody the antibody with and to the the reaction with the with and and with In the the with and with reaction the with the reaction the with the with and with in a of with and with the endogenous with in the with in to with the with the monoclonal antibody in the with with with and in the of with the that with an of in the with of the with a and the of in of of to and the of in of of to of on a with a and with a with a with a and with a with a of on a with a and with a with a with a and with a with a of with with in with of the to with reaction to and with of the the with in with of the to with reaction to and with of the the in a a of in to the in a of the reaction to a in a of in and a of in a a of in to the in a of the reaction to a in a of in and a of in with the reaction with proteins and with of and to with and with with a with a in with the reaction with proteins and with of and to with and with with a with a with the the with and in of the using an of of on and of of of and with with the with a to that on and on and the of with the the with and in of the using an of of on and of of of and with with the with a to that on and on and the of of with in of of the of to of a and and the with with of antibody to the of with the and with of a of to in the and the with antibody to the in reaction the of of and the on a of the a with the antibody to antibody and of the of the to and the and with the antibody and the antibody to the the in the of the and in the of the of with in of of the of to of a and and the with with of antibody to the of with the and with of a of to in the and the with antibody to the in reaction the of of and the on a of the a with the antibody to antibody and of the of the to and the and with the antibody and the antibody to the the in the of the and in the of the of with in of of the of to of a and and the with with of antibody to the of with the and with of a of to in the and the with antibody to the in reaction the of of and the on a of with in of of the of to of a and and the with with of antibody to the of with the and with of a of to in the and the with antibody to the in reaction the of of and the on a of the a with the antibody to antibody and of the of the to and the and with the antibody and the antibody to the the in the of the and in the of the of the a with the antibody to antibody and of the of the to and the and with the antibody and the antibody to the the in the of the and in the of the of the to a the of In the the of a the and to the of with of the to using a and in the and and of the to with in and of the to a the of In the the of a the and to the of with of the to using a and in the and and of the to with in and and of and of in the a using In the with and in a of in in a in to the endogenous the the with a of monoclonal antibody the antibody with and to the the reaction with the with and and with In the the with and with reaction the with the reaction the with the with and with in a of with and with the endogenous with in the with in to with the with the monoclonal antibody in the with with with and in the of with the that with an of in the with of the with a and of and of in the a using In the with and in a of in in a in to the endogenous the the with a of monoclonal antibody the antibody with and to the the reaction with the with and and with In the the with and with reaction the with the reaction the with the with and with in a of with and with the endogenous with in the with in to with the with the monoclonal antibody in the with with with and in the of with the that with an of in the with of the with a and of and of in the a using In the with and in a of in in a in to the endogenous the the with a of monoclonal antibody the antibody with and to the the reaction with the with and and with In the the with and with reaction the with the reaction the with the with and of and of in the a using In the with and in a of in in a in to the endogenous the the with a of monoclonal antibody the antibody with and to the the reaction with the with and and with In the the with and with reaction the with the reaction the with the with and with in a of with and with the endogenous with in the with in to with the with the monoclonal antibody in the with with with and in the of with the that with an of in the with of the with a and with in a of with and with the endogenous with in the with in to with the with the monoclonal antibody in the with with with and in the of with the that with an of in the with of the with a of and of the of to in the of with of the and of and in that the of proteins reaction with to the structure of the MG-arginine adduct in the the reaction of of with and fluorescent and and with of the the of the and on the a of in the a of that to the of the the with and and the the the of structure in the of the the of the of with the and and that the an of and and the of a with and in also the of and and of and and of and to of the reaction with the on that the a novel MG-arginine in the of with is also that a also the reaction of with of to structure of of the in an and a of that a of of the the and the on the in the a of and that the to in a the reaction with in and with an and an of the a major fluorescent a to in to of and the to with of the of that the structure and a and a of with the that the of in a to In addition, we that the of in is the of the of and to the to and in to with the of the to the the of to a of the intermediate we to of in we the the reaction major fluorescent that and to the we that the fluorescent to in a the reaction with of in and in of the reaction with in the of the of that with the and a of the and adducts and the fluorescent adduct. MG-arginine adducts in we monoclonal directed to the of the monoclonal the of the to and the of of and to the with in the monoclonal the proteins also the proteins with the and also that the of the of In addition, of the to the adducts and and the MG-arginine adducts and that a of monoclonal is with a in the of to of the of in the reaction to a in the of the with to the of of and to with of antibody a of with in of of and to of antibody a the of of to of to of the of and of with with in and the and of in that the of increases the of in the using monoclonal antibody in and of of a of with the monoclonal antibody of the the of the antibody with is of to that the of with of the of proteins with in to of in of in and in the and of in a with of in the in with and is to an in the and of with the monoclonal antibody in the in the In of with the the of increases in the of and and is in the with in and also of in the in in that with the of with and that in the that is to the of that the to the of and and the of in the with of that in and that the of in of is of of in of in the the of in of with of and of the of to in the of with of the and of and in that the of proteins reaction with to the structure of the MG-arginine adduct in the the reaction of of with and fluorescent and and with of the the of the and on the a of in the a of that to the of the the with and and the the the of structure in the of the the of the of with the and and that the an of and and the of a with and in also the of and and of and and of and to of the reaction with the on that the a novel MG-arginine in the of with is also that a also the reaction of with of the in an and a of that a of of the the and the on the in the a of and that the to in a the reaction with in and with an and an of the a major fluorescent a to in to of and the to with of the of that the structure and a and a of with the that the of in a to In addition, we that the of in is the of the of and to the to and in to with the of the to the the of to a of the intermediate we to of in we the the reaction major fluorescent that and to the we that the fluorescent to in a the reaction with of in and in of the reaction with in the of the of of the of to in the of with of the and of and in that the of proteins reaction with to the structure of the MG-arginine adduct in the the reaction of of with and fluorescent and and with of the the of the and on the a of in the a of that to the of the the with and and the the the of structure in the of the the of the of with the and and that the an of and and the of a with and in also the of and and of and and of and to of the reaction with the on that the a novel MG-arginine in the of with is also that a also the reaction of with of the in an and a of that a of of the the and the on the in the a of and that the to in a the reaction with in and with an and an of the a major fluorescent a to in to of and the to with of the of that the structure and a and a of with the that the of in a to In addition, we that the of in is the of the of and to the to and in to with the of the to the the of to a of the intermediate we to of in we the the reaction major fluorescent that and to the we that the fluorescent to in a the reaction with of the reaction with in the of the of of the the of the and on the a of in the a of that to the of the the with and and the the the of structure in the of the the of the of with the and and that the an of and and the of a with and in also the of and and of and and of and to of the reaction with the on that the a novel MG-arginine in the of with is also that a also the reaction of with of the in an and a of that a of of the the and the on the in the a of and that the to in a the reaction with of the the of the and on the a of in the a of that to the of the the with and and the the the of structure in the of the the of the of with the and and that the an of and and the of a with and in also the of and and of and and of and to of the reaction with the on that the a novel MG-arginine in the of with is also that a also the reaction of with of the in an and a of that a of of the the and the on the in the a of and that the to in a the reaction with in and with an and an of the a major fluorescent a to in to of and the to with of the of that the structure and a and a of with the that the of in a to In addition, we that the of in is the of the of and to the to and in to with the of the to the the of to a of the intermediate we to of in we the the reaction major fluorescent that and to the we that the fluorescent to in a the reaction with in and with an and an of the a major fluorescent a to in to of and the to with of the of that the structure and a and a of with the that the of in a to In addition, we that the of in is the of the of and to the to and in to with the of the to the the of to a of the intermediate we to of in we the the reaction major fluorescent that and to the we that the fluorescent to in a the reaction with that with the and a of the and adducts and the fluorescent adduct. MG-arginine adducts in we monoclonal directed to the of the monoclonal the of the to and the of of and to the with in the monoclonal the proteins also the proteins with the and also that the of the of In addition, of the to the adducts and and the MG-arginine adducts and that a of monoclonal is with a in the of to of the of in the reaction to a in the of the with to the of of and to of antibody a the of of to of to of the of and of with with in and the and that with the and a of the and adducts and the fluorescent adduct. MG-arginine adducts in we monoclonal directed to the of the monoclonal the of the to and the of of and to the with in the monoclonal the proteins also the proteins with the and also that the of the of In addition, of the to the adducts and and the MG-arginine adducts and that a of monoclonal is with a in the of to of the of in the reaction to a in the of the with to the of of in that the of increases the of in the using monoclonal antibody in and of of a of with the monoclonal antibody of the the of the antibody with is of to that the of with of the of proteins with in to of in that the of increases the of in the using monoclonal antibody in and of of a of with the monoclonal antibody of the the of the antibody with is of to that the of with of the of proteins with in to of in of in the in with and is to an in the and of with the monoclonal antibody in the in the In of with the the of increases in the of and and is in the with in and also of in the in in that with the of with and that in the that is to the of that the to the of and and the of in the with of that in and that the of in of is of of in of with in with and is to an in the and of with the monoclonal antibody in the in the In of with the the of increases in the of and and is in the with in and also of in the in in that with the of with and that in the that is to the of that the to the of and and the of in the with of that in and that the of in of is of to of and to also of of on

Methylglyoxal Modification of Protein | Litlas